- Washington has reached a $518 million settlement with drug distributors McKesson Corporation (NYSE:MCK), AmerisourceBergen Corp (NYSE:ABC), and Cardinal Health Inc (NYSE:CAH) to resolve opioid-related claims.
- Washington opted out of a $26 billion nationwide opioid settlement involving the three drug distributors and Johnson & Johnson (NYSE:JNJ).
- Reuters writes that it would have received up to $417.9 million from McKesson, Cardinal Health, and AmerisourceBergen under that settlement finalized in February.
- Also Read: JNJ, McKesson, Endo Settle $275M Opioid Claims With Alabama: Reuters.
- The state had accused the drug distributors of failing to prevent prescription pills from being diverted for illegal use. It had sought $38.2 billion to fund treatment.
- Photo by Diamond Rehab Thailand via Pixaby
Get all your news in one place.
100’s of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100’s of premium titles. One news app.
Washington, Drug Distributors Reach $518M Settlement For Opioid Claims
NYSE
MCK
McKesson
Washington D.C.
AmerisourceBergen
Cardinal Health
JNJ
AmerisourceBergen Corp
CAH
Cardinal Health Inc
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member?
Sign in here
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Our Picks